Source comparison
GHRP2: Comparison of Dose, Timing, and Administration Protocols
GHRP2 research protocols vary significantly based on experimental objectives, subject characteristics, and co-administered compounds. The table below summarizes evidence-based parameters drawn from peer-reviewed clinical trials and pharmacokinetic modeling. Do
This comparison does not assign a generated winner or score.
- GHRP2 research protocols vary significantly based on experimental objectives, subject characteristics, and co-administered compounds. The table below summarizes evidence-based parameters drawn from peer-reviewed clinical trials and pharmacokinetic modeling.
- Dose per Administration
- 0.5–0.8 mcg/kg
- 1.0–1.5 mcg/kg
- 2.0–3.0 mcg/kg
- 1.0 mcg/kg represents the inflection point of the dose-response curve. Higher doses produce diminishing GH returns with increased prolactin/cortisol risk
- Frequency
- Once daily (bedtime)
- 2–3 times daily (morning, pre-workout, bedtime)
- 3 times daily (evenly spaced)
- Twice-daily dosing (morning and bedtime) balances physiological pulsatility with practical adherence
- Timing Relative to Meals
- Fasted >2 hours before, >1 hour after
- Fasted >90 min before, >60 min after
- Fasted >3 hours before, >90 min after
- Insulin blunts GH response by 50–70%; longer fasting windows preserve secretory amplitude but reduce protocol adherence
- Reconstitution Volume
- 2 mL bacteriostatic water per 5 mg peptide
- 1 mL bacteriostatic water per 5 mg peptide (higher concentration)
- 2 mL per 5 mg yields 0.25 mg/0.1 mL, simplifying accurate dosing with standard insulin syringes; concentration doesn't affect potency if stored properly
- Injection Route
- Subcutaneous (abdominal)
- Subcutaneous (abdominal, deltoid, or thigh)
- Intramuscular (faster onset)
- Subcutaneous provides 15–20% higher AUC and more consistent plasma kinetics than intramuscular despite slightly delayed peak
- Storage Post-Reconstitution
- 2–8°C, use within 28 days
- 2–8°C, use within 14 days
- Bacteriostatic water extends stability to 28 days; sterile water limits use to 7–10 days before microbial risk increases
- Dose escalation is rarely necessary with GHRP2 because the GH response plateaus above 1.5 mcg/kg. The receptor pool is finite, and once saturated, additional ligand cannot produce additional signal. Researchers sometimes mistakenly escalate dose when GH response diminishes, but the actual cause is typically mistimed administration relative to meals or inadequate peptide storage rather than insufficient dose. We've reviewed cases where switching from a 2 mcg/kg protocol to 1 mcg/kg with stricter fasting compliance restored full GH pulse amplitude.